Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
IV Ganciclovir
DRUG
2 trials
Sponsors
Fred Hutchinson Cancer Center
Conditions
Acute Lung Injury
Acute Respiratory Distress Syndrome
Acute Respiratory Failure
Respiratory Failure
Phase 2
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Completed
NCT01335932
Fred Hutchinson Cancer Center
Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure
Start: 2011-03-10
End: 2016-10-28
Updated: 2018-08-21
Phase 3
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
Terminated
NCT04706507
Fred Hutchinson Cancer Center
Acute Respiratory Failure
Start: 2021-06-29
End: 2025-04-08
Updated: 2025-12-12
Related Papers
Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness
JAMA
2017-08-22
127 citations